Meloxicam Dosage for Cats: Surgical vs. Chronic Dosing

Meloxicam dosing in cats splits into two very different regimens depending on whether the goal is short-term surgical pain relief or long-term management of a chronic condition like osteoarthritis. For a one-time perioperative injection, the standard dose used in clinical trials is 0.3 mg/kg given under the skin before surgery. For ongoing daily oral use, the dose drops dramatically to 0.01–0.03 mg/kg once a day, typically settling at a maintenance level around 0.02 mg/kg. That tenfold-plus gap between the acute and chronic doses is not arbitrary, and understanding why it exists matters for any cat owner whose veterinarian has prescribed this drug.

The One-Time Surgical Dose

When meloxicam is used around surgery, the typical protocol is a single subcutaneous injection of 0.3 mg/kg given shortly before anesthesia. This has been studied in several randomized clinical trials. One multi-center trial in Japan allocated cats undergoing surgery to receive either robenacoxib or a single 0.3 mg/kg injection of meloxicam before anesthesia induction.¹ A separate study of 80 cats undergoing routine spay surgery found that a single 0.3 mg/kg subcutaneous dose of meloxicam provided pain relief comparable to carprofen, with no significant differences in pain or sedation scores over the following 20 hours.² A third trial involving orthopedic procedures used the same 0.3 mg/kg subcutaneous dose pre-surgically.³

The key point about perioperative use is that it is a one-time dose, not the start of a multi-day course. In the United States especially, veterinarians are cautious about giving additional doses after the initial injection due to regulatory warnings about repeated use. This contrasts with how the drug is handled in longer-term pain management, where a much smaller daily dose is used.

Chronic Dosing for Osteoarthritis

Osteoarthritis is extremely common in older cats, and meloxicam is one of the few anti-inflammatory drugs with a meaningful evidence base for long-term feline use. The oral maintenance dose used in chronic pain studies is far lower than the surgical injection: 0.01 to 0.03 mg/kg given once daily with food. In practice, veterinarians often titrate to the lowest effective dose for each individual cat, with most animals settling at around 0.02 mg/kg per day.

A prospective study of 46 cats with diagnosed osteoarthritis used this 0.01–0.03 mg/kg daily range over a mean treatment duration of about six months. Owners rated the treatment as good or excellent in roughly 85% of cases. The only adverse effect noted was gastrointestinal upset in two of the 46 cats, and no harmful effect on kidney function was detected.⁴ Those numbers are encouraging, but they come from a relatively small study, and individual cats can respond differently. Giving meloxicam with food is standard advice for chronic use because it helps buffer the stomach lining.

The liquid oral formulation commonly available for cats (typically 0.5 mg/mL in many markets) is designed for this kind of fine-tuned dosing. The dropper or syringe allows owners to measure very small volumes, which matters when you are trying to give a four-kilogram cat a dose of around 0.08 mg total. Getting that right with a tablet would be almost impossible.

Why the United States and Europe Disagree

One of the most confusing aspects of meloxicam in cats is the stark regulatory divide between the US and Europe. In Europe, meloxicam is approved for unlimited daily oral use in cats for managing musculoskeletal pain. The same drug in the United States carries a boxed warning stating that repeated use has been associated with acute kidney failure and death, and it explicitly warns against giving additional injectable or oral doses after the initial perioperative injection.⁵

This does not mean the science is different on either side of the Atlantic. The FDA’s boxed warning was largely driven by adverse event reports associated with higher or repeated full-strength doses, particularly in cats that were dehydrated, under anesthesia, or already compromised in some way. The European approach reflects the evidence from studies using much lower chronic doses with appropriate patient selection and monitoring. Many veterinary pain specialists in the US do prescribe low-dose oral meloxicam for chronic feline pain on an off-label basis, following the European evidence, but they do so with careful kidney monitoring and informed owner consent. If your vet in the US prescribes meloxicam for long-term use, they are not ignoring the FDA warning; they are weighing it against the published evidence for low-dose protocols.

Kidney Safety and Cats with Existing Kidney Disease

The kidney question is the central anxiety around meloxicam in cats, and the evidence here is more reassuring than the FDA warning alone might suggest, at least for carefully dosed and monitored patients. Meloxicam works by inhibiting cyclooxygenase enzymes, which are involved in producing prostaglandins that mediate inflammation. Some of those same prostaglandins help maintain blood flow to the kidneys, which is why anti-inflammatory drugs in this class can theoretically harm kidney function, especially in a species already prone to chronic kidney disease.

A retrospective study compared cats older than seven years receiving long-term meloxicam at a median maintenance dose of 0.02 mg/kg per day to matched controls. In cats without pre-existing kidney disease, there was no difference in kidney function markers between the meloxicam group and untreated controls. More surprisingly, in cats that already had chronic kidney disease, those receiving meloxicam actually showed less progression of their kidney disease compared to CKD-matched cats not on the drug.⁶ The study concluded that 0.02 mg/kg daily could be safely given to cats over seven, even those with stable CKD.

A separate retrospective analysis looked at longevity in cats on long-term oral meloxicam, including those with diagnosed CKD. The median survival after CKD diagnosis in the meloxicam-treated cats was about 1,608 days, which compares favorably to previously published survival times for cats with kidney disease. Long-term meloxicam did not appear to shorten the lifespan of cats with stable CKD, even those in moderate disease stages.⁷ The researchers concluded that meloxicam should be considered as part of the treatment plan for cats with chronic pain, acknowledging both quality of life and longevity.

A prospective study also specifically set out to evaluate whether low-dose meloxicam at 0.02 mg/kg per day affected kidney function in cats already diagnosed with CKD, following them over six months.⁸ The existing body of evidence, taken together, supports the idea that at the low maintenance dose, meloxicam does not accelerate kidney decline in stable patients. That said, “stable” is doing a lot of work in that sentence. A cat that is dehydrated, in a kidney crisis, or hemodynamically unstable from anesthesia is a very different patient. The risk of kidney injury goes up sharply when blood pressure or hydration are compromised, which is why perioperative settings demand extra caution and why the single-dose surgical protocol exists.

Side Effects Beyond the Kidneys

Gastrointestinal upset is the most commonly reported side effect of meloxicam in cats. This can show up as vomiting, diarrhea, or decreased appetite. In the long-term osteoarthritis study cited earlier, GI problems were the only adverse effect noted, occurring in about 4% of cats.⁹ A shorter study evaluating meloxicam over five days for acute and chronic locomotor disorders in cats found minimal side effects and described the drug as well tolerated.¹⁰

Longer-term surveillance paints a somewhat less tidy picture, as you would expect with any drug given over months or years. A study that tracked clinical use of meloxicam and another anti-inflammatory (tepoxalin) found that suspected adverse events were reported in about 18% of cats on meloxicam, occurring a median of 448 days after the prescription started.¹¹ That 18% figure comes from a small group of 22 cats, so the percentage should be taken with some caution; it means four cats had suspected problems over a year-plus of use. Still, it underlines the importance of regular veterinary check-ups, including bloodwork, for any cat on long-term meloxicam. Your vet will want to monitor kidney values, liver function, and general health at intervals that make sense for your cat’s age and condition.

If your cat starts vomiting, produces dark or tarry stools, becomes lethargic, or stops eating while on meloxicam, stop the medication and contact your veterinarian promptly. GI ulceration, while uncommon at the low chronic dose, is a risk with any anti-inflammatory drug in this class.

What Happens If a Cat Gets Too Much

Accidental overdoses do happen, whether because a cat gets into the bottle, a dose is miscalculated, or the wrong concentration of meloxicam is dispensed. Cats are far more sensitive to anti-inflammatory drug toxicity than dogs, so even a modest overdose can be serious. Signs of meloxicam toxicity can include vomiting, lethargy, loss of appetite, increased thirst and urination (early signs of kidney stress), and in severe cases, kidney failure.

Treatment for a significant overdose is supportive: intravenous fluids to protect the kidneys, gastroprotectant medications, and close monitoring of bloodwork. In at least one reported case, a more aggressive approach called manual carbon hemoperfusion was used to reduce plasma meloxicam levels in a cat following an inadvertent overdose. The technique brought down the drug’s blood concentration by about 44% and was well tolerated.¹² That is not a standard treatment available at most clinics, but it illustrates how seriously feline anti-inflammatory overdoses are taken in veterinary medicine. If you suspect your cat has ingested too much meloxicam, seek emergency veterinary care immediately. Time matters.

Practical Tips for Getting the Dose Right at Home

One of the trickier aspects of giving meloxicam to a cat at home is the precision required. A typical four-kilogram cat on a 0.02 mg/kg daily maintenance dose needs only 0.08 mg of the drug per day. Using a 0.5 mg/mL oral suspension, that translates to 0.16 mL, which is a tiny volume. The oral syringes packaged with feline meloxicam formulations are calibrated for these small amounts, and you should use the one that comes with your prescription rather than substituting a different syringe from your medicine cabinet.

A few common mistakes are worth flagging:

Wrong concentration: Dog formulations of meloxicam come in a higher concentration (1.5 mg/mL is common). Using the dog version for a cat without adjusting the volume is a recipe for a dangerous overdose. Always verify you have the feline-specific product or that your vet has specifically calculated the volume for a different concentration.
Skipping the food: Meloxicam should be given with food. This reduces the chance of stomach irritation and may improve absorption consistency.
Doubling up after a missed dose: If you miss a dose, give the next one at the normal time. Do not give a double dose to catch up.
Combining with other anti-inflammatories: Never give meloxicam alongside other anti-inflammatory drugs (including over-the-counter human painkillers like ibuprofen or aspirin) or corticosteroids without explicit veterinary direction. Stacking drugs in this class dramatically increases the risk of GI ulceration and kidney damage.

Palatability is usually not a major barrier. The feline oral suspension often has a honey or sweet flavor, and the study that evaluated long-term use specifically noted good palatability when the drug was mixed into food.¹³ That said, some cats are picky, and squirting the dose directly into the mouth with the syringe is a reasonable alternative if your cat refuses medicated food.

Monitoring Your Cat on Long-Term Meloxicam

If your cat is on meloxicam for an ongoing condition like osteoarthritis, regular veterinary monitoring is not optional. Most vets will want to see bloodwork (at minimum kidney values and a complete blood count) before starting the drug and then at regular intervals afterward, often every three to six months depending on the cat’s age and health status. Urine concentration checks can also help catch early signs of kidney trouble before blood values change.

You should also keep an eye on your cat’s behavior at home. Improvements in mobility, willingness to jump, grooming habits, and general mood are all signs the medication is working. Conversely, a return of stiffness or reluctance to move may signal that the dose needs adjustment. The goal with chronic meloxicam therapy is always the lowest effective dose: enough to keep your cat comfortable, but no more than necessary. Your vet may periodically try reducing the dose slightly to see whether your cat still needs the full amount, especially if the arthritis seems stable.

Hydration matters more than usual for cats on anti-inflammatory drugs. Make sure fresh water is always available, and consider a water fountain if your cat is the type that prefers running water. Wet food diets are also helpful for maintaining hydration, which in turn supports kidney perfusion and reduces one of the risk factors for anti-inflammatory-related kidney stress.

When Meloxicam Is Not the Right Choice

Not every cat with pain should be on meloxicam. Cats with unstable kidney disease, active gastrointestinal bleeding, severe liver dysfunction, or clotting disorders are generally poor candidates. Cats that are dehydrated or hypotensive (low blood pressure) should not receive the drug until those problems are corrected, because reduced blood flow to the kidneys under those conditions makes anti-inflammatory-related kidney injury far more likely.

Very young kittens also require extra caution, as their organ systems are still maturing and their ability to metabolize drugs may differ from adult cats. Pregnant or nursing cats are another group where meloxicam is typically avoided unless the benefit clearly outweighs the risk.

For cats that cannot tolerate meloxicam, alternative pain management options exist. Other anti-inflammatory drugs may occasionally be considered, though cats have limited options in this class compared to dogs. Non-pharmaceutical approaches such as joint supplements, weight management, environmental modifications (ramps, heated beds, low-entry litter boxes), physical rehabilitation, acupuncture, and laser therapy can all contribute to pain relief. A newer class of injectable monoclonal antibody therapies targeting nerve growth factor has also become available for feline osteoarthritis pain in several markets, offering a completely different mechanism of action that avoids the anti-inflammatory pathway entirely.¹⁴ These monthly injections have changed the landscape for cats whose owners or veterinarians are uncomfortable with daily oral anti-inflammatory use.